Latest filing published 22 Nov 2024 for ResMed Inc.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +6.2%Entry US$19.75 · Close at T+365 US$20.99
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Richard Sulpizio: trading record in brief
Filings by Richard Sulpizio span 2 companies, the busiest being ResMed Inc and Qualcomm Inc/de. Between 4 May 2006 and 20 November 2024, the trades on record add up to 40 filings.
Both buying and selling appear: 1 purchase worth €331k, against 10 sales worth €39.5M. The net balance comes to €39.2M on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 13 share grants and 13 option exercises.
The latest filing, published on 22 November 2024, reports a share grant in ResMed Inc. The last purchase on record was published on 22 August 2006, which is 7,383 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Richard Sulpizio
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,083 shares0ResMed Common StockSEC:0001127602-24-027904:0
- 1,768 shares0ResMed Common StockSEC:0001127602-23-028092:0
- 1,122 shares0ResMed Common StockSEC:0001127602-22-026076:0
- 1,187 shares0ResMed Common StockSEC:0001127602-20-029763:0
- 1,727 shares0ResMed Common StockSEC:0001127602-19-033669:0
- 2,533 shares0ResMed Common StockSEC:0001567619-18-006566:0
- 28,403 shares@ US$27.584.3% of flowResMed Common StockSEC:0001140361-18-026731:0
- 28,403 shares@ US$102.7815.9% of flowResMed Common StockSEC:0001140361-18-026731:1
- 2,991 shares0ResMed Common StockSEC:0001140361-17-043345:0
- 24,390 shares@ US$33.704.4% of flowResMed Common StockSEC:0001140361-17-031347:0
- 24,390 shares@ US$73.859.7% of flowResMed Common StockSEC:0001140361-17-031347:1
- 65,887 shares@ US$77.8229.2% of flowResMed Common StockSEC:0001140361-17-026325:0
- 65,887 shares0ResMed Common StockSEC:0001140361-17-026144:0
- 65,887 shares0ResMed Common StockSEC:0001140361-17-026144:1
- 65,887 shares0ResMed Common StockSEC:0001140361-17-026035:0
- 4,429 shares0ResMed Common StockSEC:0001140361-16-087134:0
- 4,429 shares0ResMed Common StockSEC:0001140361-16-087138:0
- 36,000 shares@ US$25.545.2% of flowResMed Common StockSEC:0001140361-16-075829:0
- 36,000 shares@ US$70.1514.3% of flowResMed Common StockSEC:0001140361-16-075829:1
- 36,000 shares@ US$23.885.0% of flowResMed Common StockSEC:0001140361-16-055440:0
- 36,000 shares@ US$57.8812.0% of flowResMed Common StockSEC:0001140361-16-055440:1
- 4,360 shares0ResMed Common StockSEC:0001140361-15-042668:0
- 36,000 shares@ US$15.52ResMed Common StockSEC:0001140361-15-033947:0
- 10,860 shares@ US$51.83ResMed Common StockSEC:0001140361-15-033947:1
- 72,000 shares@ US$18.01ResMed Common StockSEC:0001140361-15-004606:0
25 of 40 declarations
